---
bio-current:
  name-cn: 
  name-en: Richard Gelber
  email: 
    - gelber@jimmy.harvard.edu # 如果有多个邮箱，请都填写上
  sex: male
  birth-date: # yyyy 到年即可
  university: Harvard University 
  school: Dept, of Biostatistics [https://www.hsph.harvard.edu/biostatistics] # 格式：学院名称[学院官网链接]
  major: Biostatistics
  title-raw: Professor # 主页原始字符串 
  title: Professor
  interests: 
    - None # 分点罗列，依次以 ‘-’ 开头
  homepage: 
    - https://www.hsph.harvard.edu/richard-gelber/ # 如果有多个主页，请都填写上
  github: 
  googlescholar: https://scholar.google.com/citations?hl=zh-CN&user=-8N5_80AAAAJ 
  aminer: None # 从这里查找 https://www.aminer.org/search/person
  status: 在职
  last-update: # yyyy-mm-dd 最近一次信息更新日期
edu-phd:  # 读博经历
  university: Cornell University
  school: Biostatistics
  email: 
  date-start: 
  date-end: 1975
  advisor: # 格式：导师名 [邮箱/网址]
  degree: # phd
edu-master: # 硕士经历，没有或找不到，可不填
  university: 
  school: 
  date-start: 
  date-end: 
  advisor:
edu-bachelor:  # 本科经历，没有或找不到，可不填
  university: 
  school: 
  major: 
  date-start: 
  date-end: 
page-other:   # 其他有用的链接，部分可从学者主页子栏目获得
  publication: 
  research: 
  software: 
  project: 
  blog: 
  arxiv: 
  linkedin: 
  weibo:
  twitter:
  wikipedia:
  baidu-baike:
collaboration: # 合作研究，关注学者和其他哪些学科的人合作，具体研究哪些主题
  - 
    with: # 合作者
    project: # 研究主题
  - 
    with: 
    project: 
group: # 所属团队，学者可能有不同的兴趣小组，可以列上去
job-faculty-1: # 所属机构，若有多个增加编号即可，字段填写参看示例文件
  university: Harvard University 
  school: Dept, of Biostatistics [https://www.hsph.harvard.edu/biostatistics] # 格式：学院名称[学院官网链接]
  major: Biostatistics
  email: gelber@jimmy.harvard.edu
  homepage: https://www.hsph.harvard.edu/richard-gelber/ # 机构内学者主页
  date-start: 
  title: Professor
  type: 
job-post-doc: # 博士后研究员，字段填写参看示例文件，若无可不填写
  university: 
  school: 
  email: 
  date-start: 
  date-end: 
  advisor: 
---

# Profile

![Richard Gelber](https://cdn1.sph.harvard.edu/wp-content/uploads/sites/534/2012/09/siteheader.jpg)

# Biography[English]

Dr. Gelber developed the Q-TWiST method (Quality-adjusted Time Without Symptoms of disease and Toxicity of treatment) for incorporating quality-of-life considerations into treatment comparisons. This quality-adjusted survival technique provides a framework to balance the benefits of disease control against the costs of treatment side effects using threshold utility analysis and patient preferences. He also created the STEPP method (Subpopulation Treatment Effect Pattern Plot) which uses data from randomized clinical trials to graphically illustrate the pattern of differences in treatment effectiveness as a function of a covariate of interest. Dr. Gelber has directed the Statistical Center for the International Breast Cancer Study Group since 1978. This consortium of institutions conducts Phase III clinical trials for adjuvant therapy for breast cancer. In addition, he is the senior biostatistician for two major studies of adjuvant treatment for HER2-positive breast cancer conducted by the Breast International Group (the HERA and ALTTO trials).

# Biography[中文]

# Interests[English]

# Interests[中文]

# Education[English]

- Ph.D. in Biostatistics (1975)
    
    Cornell University

# Education[中文]

# Awards[English]

# Awards[中文]

# Talks[English]

# Talks[中文]

# Work experience[English]

# Work experience[中文]

# Publication[English]

- Martine J Piccart-Gebhart, Marion Procter, Brian Leyland-Jones, Aron Goldhirsch, Michael Untch, Ian Smith, Luca Gianni, Jose Baselga, Richard Bell, Christian Jackisch, David Cameron, Mitch Dowsett, Carlos H Barrios, Günther Steger, Chiun-Shen Huang, Michael Andersson, Moshe Inbar, Mikhail Lichinitser, István Láng, Ulrike Nitz, Hiroji Iwata, Christoph Thomssen, Caroline Lohrisch, Thomas M Suter, Josef Rüschoff, Tamás Sütő, Victoria Greatorex, Carol Ward, Carolyn Straehle, Eleanor McFadden, M Stella Dolci, **Richard D Gelber**. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer
- Edward M Connor, Rhoda S Sperling, **Richard Gelber**, Pavel Kiselev, Gwendolyn Scott, Mary Jo O'sullivan, Russell VanDyke, Mohammed Bey, William Shearer, Robert L Jacobson, Eleanor Jimenez, Edward O'Neill, Brigitte Bazin, Jean-Francois Delfraissy, Mary Culnane, Robert Coombs, Mary Elkins, Jack Moye, Pamela Stratton, James Balsley. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment
- Aron Goldhirsch, William C Wood, Alan S Coates, **Richard D Gelber**, Beat Thürlimann, H-J Senn. Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
- Ian Smith, Marion Procter, **Richard D Gelber**, Sébastien Guillaume, Andrea Feyereislova, Mitch Dowsett, Aron Goldhirsch, Michael Untch, Gabriella Mariani, Jose Baselga, Manfred Kaufmann, David Cameron, Richard Bell, Jonas Bergh, Robert Coleman, Andrew Wardley, Nadia Harbeck, Roberto I Lopez, Peter Mallmann, Karen Gelmon, Nicholas Wilcken, Erik Wist, Pedro Sánchez Rovira, Martine J Piccart-Gebhart, HERA Study Team. 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial
- Aron Goldhirsch, James N Ingle, **RD Gelber**, AS Coates, Beat Thürlimann, H-J Senn. Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009

# Publication[中文]

# Information Reference

-  homepage: https://www.hsph.harvard.edu/richard-gelber/
-  googlescholar: https://scholar.google.com/citations?hl=zh-CN&user=-8N5_80AAAAJ
-  aminer: 

# Notes